| Předmět: |
|
| Zdroj: |
Drug Week; 6/28/2024, p619-619, 1p |
| Abstrakt: |
A recent study conducted by researchers at the Dnipropetrovsk Medical Academy of Health Ministry of Ukraine explores the potential of erythropoietin as a treatment option for Alzheimer's disease. The researchers conducted a comprehensive review of the literature and concluded that erythropoietin shows promise in mitigating the progression of Alzheimer's disease with minimal side effects. The study emphasizes the need for effective treatment options for Alzheimer's disease, which is the most common cause of dementia and places a significant burden on the healthcare system. Further research is needed to fully understand the mechanisms and potential benefits of erythropoietin in Alzheimer's disease treatment. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
